Stonepine Capital Management, LLC 13D and 13G filings for Aytu BioPharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 5:36 pm Purchase |
2024-09-30 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 626,862 9.990% |
61,378 (+10.85%) |
Filing |
| 2024-02-13 4:25 pm Purchase |
2023-12-31 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 565,484 9.990% |
1,642 (+0.29%) |
Filing |
| 2023-06-16 4:48 pm Purchase |
2023-06-09 | 13G | Aytu BioPharma, Inc. AYTU |
Stonepine Capital Management, LLC | 563,842 9.990% |
563,842 (New Position) |
Filing |